NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), is offering a funding opportunity for pilot studies aimed at planning clinical trials (R34) focused on heart, lung, blood, and sleep disorders. This Notice of Funding Opportunity (NOFO) seeks to gather essential data to inform the design of Phase II-IV trials, emphasizing the need for research that addresses knowledge gaps necessary for future trials. A critical requirement of the application process is the inclusion of a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity within scientific teams, aligning with NIH’s goals of advancing scientific innovation. The funding amount can reach up to $450,000 over three years, with key deadlines including an open submission date starting January 1, 2024, and the first application due by February 16, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.